当前位置: X-MOL 学术Eur. J. Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2024-06-07 , DOI: 10.1002/ejhf.3286
Stefan D Anker 1, 2, 3 , Tim Friede 4, 5 , Ralph Stephan von Bardeleben 6 , Javed Butler 7, 8 , Muhammad Shahzeb Khan 9 , Monika Diek 1, 2, 3 , Jutta Heinrich 10 , Martin Geyer 6 , Marius Placzek 4, 5 , Roberto Ferrari 11 , William T Abraham 12 , Ottavio Alfieri 13 , Angelo Auricchio 14 , Antoni Bayes-Genis 15 , John G F Cleland 16 , Gerasimos Filippatos 17 , Finn Gustafsson 18 , Wilhelm Haverkamp 1 , Malte Kelm 19, 20 , Karl-Heinz Kuck 21 , Ulf Landmesser 22, 23, 24 , Aldo P Maggioni 25 , Marco Metra 26 , Vlasis Ninios 27 , Mark C Petrie 16 , Tienush Rassaf 28 , Frank Ruschitzka 29, 30 , Ulrich Schäfer 31 , P Christian Schulze 32 , Konstantinos Spargias 33 , Alec Vahanian 34 , Jose Luis Zamorano 35, 36 , Andreas Zeiher 37, 38 , Mahir Karakas 39, 40 , Friedrich Koehler 24, 41, 42 , Mitja Lainscak 43, 44 , Alper Öner 45 , Nikolaos Mezilis 46 , Efstratios K Theofilogiannakos 46 , Ilias Ninios 27 , Michael Chrissoheris 33 , Panagiota Kourkoveli 33 , Konstantinos Papadopoulos 27, 33 , Grzegorz Smolka 47 , Wojciech Wojakowski 47 , Krzysztof Reczuch 48 , Fausto J Pinto 49 , Krzysztof Zmudka 50 , Zbigniew Kalarus 51 , Marianna Adamo 26 , Evelyn Santiago-Vacas 15 , Tobias Friedrich Ruf 6 , Michael Gross 52 , Joern Tongers 53 , Gerd Hasenfuß 2, 3 , Wolfgang Schillinger 2, 54 , Piotr Ponikowski 49
Affiliation  

The RESHAPE-HF2 trial is designed to assess the efficacy and safety of the MitraClip device system for the treatment of clinically important functional mitral regurgitation (FMR) in patients with heart failure (HF). This report describes the baseline characteristics of patients enrolled in the RESHAPE-HF2 trial compared to those enrolled in the COAPT and MITRA-FR trials.

中文翻译:


有症状心力衰竭患者中度至重度或重度功能性二尖瓣反流的经皮修复术:RESHAPE-HF2 试验中患者的基线特征以及与 COAPT 和 MITRA-FR 试验的比较



RESHAPE-HF2 试验旨在评估 MitraClip 装置系统治疗心力衰竭 (HF) 患者临床重要的功能性二尖瓣反流 (FMR) 的有效性和安全性。本报告描述了参加 RESHAPE-HF2 试验的患者与参加 COAPT 和 MITRA-FR 试验的患者的基线特征。
更新日期:2024-06-07
down
wechat
bug